These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22410492)

  • 21. Chronic Kidney Disease Severity Is Associated With Selective Expansion of a Distinctive Intermediate Monocyte Subpopulation.
    Naicker SD; Cormican S; Griffin TP; Maretto S; Martin WP; Ferguson JP; Cotter D; Connaughton EP; Dennedy MC; Griffin MD
    Front Immunol; 2018; 9():2845. PubMed ID: 30619252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated CD14++CD16- monocytes predict cardiovascular events.
    Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness.
    SahBandar IN; Ndhlovu LC; Saiki K; Kohorn LB; Peterson MM; D'Antoni ML; Shiramizu B; Shikuma CM; Chow DC
    J Atheroscler Thromb; 2020 May; 27(5):441-448. PubMed ID: 31588100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease.
    Lee JW; Cho E; Kim MG; Jo SK; Cho WY; Kim HK
    Kidney Res Clin Pract; 2013 Dec; 32(4):147-52. PubMed ID: 26877933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease.
    Borges Bonan N; Schepers E; Pecoits-Filho R; Dhondt A; Pletinck A; De Somer F; Vanholder R; Van Biesen W; Moreno-Amaral A; Glorieux G
    Sci Rep; 2019 Jul; 9(1):10236. PubMed ID: 31308443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making a difference: monocyte heterogeneity in cardiovascular disease.
    Hilgendorf I; Swirski FK
    Curr Atheroscler Rep; 2012 Oct; 14(5):450-9. PubMed ID: 22847772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
    Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
    Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis.
    Xiang Y; Liang B; Zhang X; Zheng F
    Int J Med Sci; 2020; 17(14):2171-2179. PubMed ID: 32922178
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.
    Ruiz-Limon P; Ortega-Castro R; Barbarroja N; Perez-Sanchez C; Jamin C; Patiño-Trives AM; Luque-Tevar M; Ibáñez-Costa A; Perez-Sanchez L; de la Rosa IA; Abalos-Aguilera M; Jimenez-Gomez Y; Calvo-Gutierrez J; Font P; Escudero-Contreras A; Alarcon-Riquelme ME; Collantes-Estevez E; López-Pedrera C;
    Front Immunol; 2019; 10():1111. PubMed ID: 31169830
    [No Abstract]   [Full Text] [Related]  

  • 30. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated circulating CD14
    Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
    Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment.
    Sester U; Sester M; Heine G; Kaul H; Girndt M; Köhler H
    Nephrol Dial Transplant; 2001 Jul; 16(7):1402-8. PubMed ID: 11427632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.
    Tapp LD; Shantsila E; Wrigley BJ; Pamukcu B; Lip GY
    J Thromb Haemost; 2012 Jul; 10(7):1231-41. PubMed ID: 22212813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CD36 expression on circulating monocytes subsets in children on regular hemodialysis.
    Mansour N; Abdel-Salam M; Hammad R; Moustafa S; Maghraby H
    Egypt J Immunol; 2021 Oct; 28(4):224-232. PubMed ID: 34882371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset.
    Draude G; von Hundelshausen P; Frankenberger M; Ziegler-Heitbrock HW; Weber C
    Am J Physiol; 1999 Apr; 276(4):H1144-9. PubMed ID: 10199836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events.
    Zhou X; Liu XL; Ji WJ; Liu JX; Guo ZZ; Ren D; Ma YQ; Zeng S; Xu ZW; Li HX; Wang PP; Zhang Z; Li YM; Benefield BC; Zawada AM; Thorp EB; Lee DC; Heine GH
    Medicine (Baltimore); 2016 May; 95(18):e3466. PubMed ID: 27149446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating CD14
    Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
    J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
    Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
    Front Immunol; 2019; 10():1761. PubMed ID: 31402918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte-macrophage polarization balance in pre-diabetic individuals.
    Fadini GP; Cappellari R; Mazzucato M; Agostini C; Vigili de Kreutzenberg S; Avogaro A
    Acta Diabetol; 2013 Dec; 50(6):977-82. PubMed ID: 24085683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.